CST BLOG

The official blog of Cell Signaling Technology, where we discuss what to expect from your time at the bench, share tips, tricks, and information.

The Researcher's Guide to the Hallmarks of Cancer Research Targets

Read More
All Posts

If you haven’t heard already, it’s CST’s 20th anniversary. Woohoo! You could say this year is kind of a big deal for us. We have a lot to celebrate. However, once we started listing the successes over the years, we realized that we are most proud of what you— the researchers worldwide—have accomplished using our reagents. After all, we don’t live in a vacuum. We exist to serve you and enable important discoveries and the development of cures.

18-CEL-48064-Blog-Hallmarks-of-Cancer-11-Recap-20-Years-v4

It was around the same time that CST first opened its doors that Doctors Robert Weinberg and Douglas Hanahan were working on the Hallmarks of Cancer. The initial publication in Cell in 2001 changed the disease research world forever. At that time, most researchers were focused on the nature of aberrant signaling in their specific research area. These visionaries thought; What if the complexity of cancer could be broken down into smaller subsets of general underlying principles? For them, it seemed a useful exercise to step back and look at the commonality between what all researchers had discovered.

Weinberg and Hanahan wanted to contribute something new and useful, a tool for researchers to further discovery. That resonated with us and gave us the idea for our Hallmarks of Cancer series. Much has been written about the hallmarks themselves, but we thought we could expand on their story with what we know best: cell signaling and research targets.

Which pathways are hijacked or manipulated in each of the hallmarks? Which proteins can be targeted to combat the adverse mechanisms of cancer cells? These are important questions, and this blog series helps provide the answers.

Jump to a hallmark to learn more:

Would you prefer all this information in one, handy guide? Download a digital copy of The Guide to the Hallmarks of Cancer Research Targets.

Chris Sumner
Chris Sumner
Chris Sumner was a writer at CST.

Recent Posts

Hallmarks of Cancer: Nonmutational Epigenetic Reprogramming

Nonmutational epigenetic reprogramming is a defining characteristic of cancer, whereby tumor cells acquir...
Curtis Desilets Nov 5, 2025

CiteAb Top 100: The Top-Ranked Recombinant Antibodies & Discovery Reagents

Each year, the CiteAb Top 100 Antibodies report highlights the reagents cited most frequently in publishe...
Alexandra Foley Oct 31, 2025

Hallmarks of Cancer: Unlocking Phenotypic Plasticity

In 2022, an update was made to the Hallmarks of Cancer framework to expand beyond the eight hallmarks and...
Antony Wood, PhD Oct 22, 2025